BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  aTyr Pharma Presents Analyses Of Resolaris Phase Ib/II Trial In Patients With Limb Girdle Muscular Dystrophy 2B And Facioscapulohumeral Muscular Dystrophy At The American Academy of Neurology 69th Annual Meeting

  April 24, 2017

   · 

  5 min read
• Drug Development

  aTyr Pharma Announces Promising Top-Line Results From Resolaris Phase Ib/II Clinical Trial In Patients With Early Onset Facioscapulohumeral Muscular Dystrophy

  April 24, 2017

   · 

  6 min read
• Business

  Invitae To Announce First Quarter 2017 Financial Results And Host Conference Call On May 8, 2017

  April 24, 2017

   · 

  1 min read
• Drug Development

  Matinas BioPharma Presents Positive Preclinical Data Of Orally Available DNA Vaccines At The 27th Annual European Congress Of Clinical Microbiology And Infectious Diseases

  April 24, 2017

   · 

  5 min read
• Business

  Aptose Biosciences To Release First Quarter Ended March 31, 2017 Financial Results And Hold Conference Call On May 11, 2017

  April 24, 2017

   · 

  4 min read
• Drug Development

  Bristol-Myers Squibb’s NASH Candidate Hits Main Goals In Mid-Stage Study

  April 24, 2017

   · 

  6 min read
• Drug Development

  Sirtex Medical Release: SIR-Spheres Y-90 Resin Microspheres Substantially Improves Quality Of Survival In Primary Liver Cancer, New Study Against Standard Treatment Shows

  April 24, 2017

   · 

  9 min read
• Biotech Bay

  California Life Sciences Institute Names 2017 Winner Of Amgen Bay Area BioGENEius Competition

  April 24, 2017

   · 

  4 min read
• Galapagos Announces Closing Of Public Offering Of American Depositary Shares For Gross Proceeds Of €363.9 Million

  April 24, 2017

   · 

  2 min read
• Business

  Penumbra Appoints Bridget O’Rourke To Its Board Of Directors

  April 24, 2017

   · 

  2 min read